As expected, the inhibitors blocked VSVFLuc-G infections in a dose-dependent manner, but did not block VSVFLuc-MLV/Env and VSVFLuc-MV/FH infections (Fig. 3C, D). This evidence concerns the gene ERVW-1 and infection.